First-in-human phase I trial of prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-refractory prostate cancer

被引：5
|
作者：
Kantoff, P.
Petrylak, D. P.
Pomerantz, M.
Israel, R. J.
Olson, W. C.
Ramakrishna, T.
Morris, S.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Columbia Univ, Med Ctr, New York, NY USA
[3] Progen Pharmaceut Inc, Tarrytown, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.tps245
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS245
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer
    Sun, Michael
    Niaz, Muhammad Junaid
    Niaz, Muhammad Obaid
    Tagawa, Scott T.
    CURRENT ONCOLOGY REPORTS, 2021, 23 (05)
  • [22] Prostate-specific membrane antigen (PSMA) expression as a predictor of prostate cancer progression
    Perner, SR
    Hofer, MD
    Li, H
    Kuefer, R
    Gschwend, J
    Hautmann, R
    Moeller, P
    Rubin, MA
    MODERN PATHOLOGY, 2006, 19 : 155A - 155A
  • [23] Advances in Prostate-Specific Membrane Antigen (PSMA)-Targeted Phototheranostics of Prostate Cancer
    Wang, He
    He, Zhangxin
    Liu, Xiao-Ang
    Huang, Yuhua
    Hou, Jianquan
    Zhang, Weijie
    Ding, Dan
    SMALL STRUCTURES, 2022, 3 (08):
  • [24] Prostate-specific membrane antigen (PSMA)-based diagnostics and treatment of prostate cancer
    Afshar-Oromieh, A.
    Alberts, I.
    Sachpekidis, C.
    Rominger, A.
    UROLOGE, 2019, 58 (12): : 1429 - 1434
  • [25] Prostate-specific membrane antigen (PSMA) expression as a predictor of prostate cancer progression
    Hofer, MD
    Perner, S
    Li, HJ
    Kuefer, R
    Hautmann, RE
    Gschwend, JE
    Moeller, P
    Rubin, MA
    JOURNAL OF UROLOGY, 2006, 175 (04): : 155 - 156
  • [26] Glycoforms of human prostate-specific membrane antigen (PSMA) in human cells and prostate tissue
    Yuan, Wei
    Liu, Baoqin
    Sanda, Miloslav
    Wei, Renhuizi
    Benicky, Julius
    Novakova, Zora
    Barinka, Cyril
    Goldman, Radoslav
    PROSTATE, 2022, 82 (01): : 132 - 144
  • [27] A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer
    Slovin, Susan F.
    Kehoe, Marissa
    Durso, Robert
    Fernandez, Celina
    Olson, William
    Gao, Jian P.
    Israel, Robert
    Scher, Howard I.
    Morris, Stephen
    VACCINE, 2013, 31 (06) : 943 - 949
  • [28] In Vitro and In Vivo Responses of Advanced Prostate Tumors to PSMA ADC, an Auristatin-Conjugated Antibody to Prostate-Specific Membrane Antigen
    Wang, Xinning
    Ma, Dangshe
    Olson, William C.
    Heston, Warren D. W.
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (09) : 1728 - 1739
  • [29] Pharmacological upregulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells
    Kranzbuhler, Benedikt
    Salemi, Souzan
    Umbricht, Christoph A.
    Mueller, Cristina
    Burger, Irene A.
    Sulser, Tullio
    Eberli, Daniel
    PROSTATE, 2018, 78 (10): : 758 - 765
  • [30] Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells
    Lapidus, RG
    Tiffany, CW
    Isaacs, JT
    Slusher, BS
    PROSTATE, 2000, 45 (04): : 350 - 354
12345